Based on a continuing trend of decreased mortality in the ongoing Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer (BTC), the analyses of overall survival (OS) and progression-free survival (PFS) are expected in late Q1 2026.A new response in a third indication has been observed in the fifth and final dosing cohort of the Phase 1 dose-escalation study of CTX-8371 (PD-1 x PD-L1 bispecific antibody); no dose-limiting toxicities have ...

BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported business updates and financial results for the third quarter of 2025 ending September 30, 2025. Business Updates On October 23, 2025, the Company received $80 million in gross proceeds in a private placement, before deducting fees and other expenses. The financing in ...

MediWound to Report Third Quarter 2025 Financial Results Conference call and webcast scheduled for Thursday, November 20 at 8:30 a.m. Eastern Time YAVNE, Israel, November 5, 2025 -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its financial results for the third quarter ended September 30, 2025 on Thursday, November 20, 2025. Following the release, the Company’s management will host a confere ...

LOUISVILLE, Ky., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage and media solutions, today announced that it will participate in the 16th Annual Craig-Hallum Alpha Select Conference at the Sheraton NY Times Square Hotel on Tuesday, November 18. The day will consist of one-on-one meetings with management, and institutional investors can contact Craig-Hallum directly to set up time with the Compan ...

Transaction Significantly Reduces Corporate Debt, Increases Financial Flexibility, and Strengthens Balance SheetRENO, Nev., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced the Company has finalized its agreements to restructure its outstanding indebtedness with its lenders under its existing term loan agreement (the “Term Loan Agreement”). The restructuring sub ...

SHENZHEN, China, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced that it has entered into a strategic framework agreement with Lenovo Group and its subsidiaries, one of the world's leading technology companies and a Fortune Global 500 enterprise. The strategic framework partnership agreement establishes Jayud as a key logist ...

Webcast scheduled for Monday, November 10 at 12:00 pm ESTREDWOOD CITY, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that the company will host a virtual investor event via webcast on Monday, November 10, 2025, from 12:00 – 1:30 pm EST. The event will highlight the market opportunity and clinical development of ersodetug, which is currently be ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver B.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- TERRA CLEAN ENERGY CORP. (“Terra” or the “Company”) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0) is pleased to announce, that further to its news release dated October 20, 2025, the Company has closed its non-brokered private placement offering (the “Offering”) issuing a total of 17,641,293 units of the Company (“Units”) for gross proceeds of $2,469,781.02. Each Unit c ...

ORIGIN 3 trial primary endpoint results for Atacicept in IgA nephropathy (IgAN) selected as a featured late-breaking oral presentation during opening plenary session of American Society of Nephrology (ASN) Kidney Week 2025Biologics License Application (BLA) submission through the Accelerated Approval Program for atacicept for the treatment of IgAN to U.S. FDA expected in Q4; potential U.S. commercial launch of atacicept in 2026Actively enrolling patients in the PIONEER, atacicept monthly dose range finding, ...

NANJING, China, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The 14th Suzhou Creative and Design Cultural Industry Expo came to an end on November 2nd. This cultural gala rooted in the Jiangnan region (the southern area of the Yangtze River Delta in China), with the core theme of "Culture and Creativity Make Life More Interesting", set a new historical high in terms of exhibition scale, number of visitors and achievements - within the 41,000-square-meter exhibition hall, there were over 100,000 person-times of visits ...